Muscular dystrophy of the childhood or classical Duchenne-type is classified by: (1) the onset of muscular weakness in the pelvic girdle and lower limb muscles, usually before the 7th year of -life; (2) appearance almost exclusively in male children; (3) presence of enlargement ("pseudo-hypertrophy") in the calves and deltoids; and (4) a rapid progression of weakness to other muscle groups, leading to death by age 15.
The disease is inherited as a sex-linked trait. Males are affected-females rarely so. The carrier state has been detected in the female in some recent studies which utilized appropriate serum enzyme measurements.1-4 The dystrophic gene is carried on the X-chromosome and usually only manifests itself in the male. Thus, it is interesting that about 40 females with fairly "classical" Duchenne-type dystrophy have been recorded in the literature.' These could be explained by: (a) the mating of a carrier female with an affected male; (b) the mating of a carrier female with a normal male who had undergone mutation on his X-chromosome; and (c) a female with an XO-chromosome complement (Turner's syndrome), the mutant gene being on the single X-chromosome and showing full manifestation. Of these suggestions (a) is unlikely, since affected males rarely reproduce; (b) is very improbable, since Walton6 has estimated that this may only occur once in 1,000 million population or one case for every 50,000 dystrophic males; and (c) remains a possibility and could only be ruled out by chromatin determinations in these patients. One of the female patients described by Walton6 may have had an XO-chromosome complement.
Forms of juvenile muscular dystrophy which begin in the lower limbs, as proposed by Becker,78 include (a) malignant X-chromosomal type (Duchenne-type), (b) benign X-chromosomal type, and (c) autosomal recessive type which includes the limb-girdle form of others9-" and often overlaps the benign X-chromosome type clinically. Discriminant functions based on historical, physical, and laboratory findings have been proposed as a method for improving separation into genetic entities. 12 Increased serum levels of transaminases, aldolases, and other serum enzymes have been used to confirm the diagnosis of dystrophy or for recognition of preclinical cases.13 One enzyme, creatine phosphokinase (CPK), is proportionately higher in the serum of dystrophic subjects than are the other enzymes.A 4. 14 Recent reports indicate that CPK activity is a fairly sensitive measurement of the carrier state;4' 15 15 of 17 females, assumed to be carriers of the gene for Duchennetype dystrophy, had elevated CPK activity. In families with affected male siblings and Duchenne-type dystrophy, 50 per cent of the unaffected female siblings had elevated CPK activity. The series is small, but fits the expected proportion. '5 Evidence to be presented suggests that the carrier state in the unaffected female may be identified by CPK elevation and histological changes in the muscle. Further, it is suggested that determination of the carrier state is most reliable in the young child, and that enzyme and histological changes in the muscle in the carrier state signify the existence of a subclinical form of dystrophy. This finding, as well as the infrequent reports of clinically affected females, is best explained on the basis of X-chromosomal mosaicism.
Methods.-CPK measurements were based upon the method described by Tanzer and Gilvarg. '6 Normal values ranged up to 1.5 units. Muscle sections were stained routinely with hematoxylin and eosin and with Azure B at pH 4.0, which specifically colorizes cells blue when RNA is present. ' 
Prior treatment with
RNAase eliminates all staining in these muscle fibers.
Results.-EEnzyme studies: In all, 84 members from 15 families were studied with physical examination, serum CPK values, and muscle biopsies, where appropriate. Each family was identified through an affected male. The values for known carriers, possible carriers, female siblings, and more remote relatives may be grouped as follows:
1. Eight known carrier females: 4 of 8 mothers had elevated serum activity levels for CPK. These mothers were assumed to be carriers if they had (a) more than one affected son, (b) an affected son and daughter whose CPK was elevated, (c) other male members with Duchenne-type dystrophy on the maternal side of the family.
2. Seven possible carrier females: 4 of 7 had elevated CPK values. This includes those mothers with an affected son only, and no daughters with increased CPK activity.
3. Twelve female siblings with dystrophic brothers; 5 of the 12 had elevated CPK levels, a value quite close to the expected proportion of 50 per cent.
4. Six of 25 clinically normal younger brothers with high CPK levels. Muscle biopsy on each revealed the changes of early preclinical muscular dystrophy. 19 5. Thirty-four clinically normal brothers with normal CPK levels. Muscle biopsies on four of these children were normal. 6 Figure 1 wase X elevated. The normal value in the carrier mother will be discussed later in more detail.
Histological studies: Muscle biopsies were obtained from an anterior thigh muscle in three girls, each of whom had an elevation of the CPK level (97 units, 13 units, 8 units) . No changes were found in the girl with the lowest CPK value. The patient with the highest CPK value had two biopsies from different areas within the same muscle. One of these showed moderately typical histological features of muscular dystrophy, whereas the other had only subtle alterations with the usual staining procedures (Fig. 3) The expected frequency with which CPK elevations should be found in the carrier mother is 100 per cent. However, only 4 of 8 assumed carrier mothers and 4 of 7 possible carriers had elevated enzyme activity. The mother in Figure 2 (II 2) had a normal value. This failure to identify the carrier state in II 2, as well as in other mothers, may be explained by the fact that the dystrophic muscle fibers which she may have had during childhood underwent destruction, leaving few, if any, abnormal muscle fibers at this time which could contribute to the serum CPK enzyme pool. This explanation is supported by the finding that in affected males the serum enzyme levels are highest in the preclinical and clinical phases of dystrophy, and tend to fall gradually toward normal values as the muscle wasting advances and the subject becomes confined to bed or a wheelchair.20
Previous estimates indicate that about 50 per cent of functional muscle must be lost before any clinical evidence of weakness becomes apparent in carrying out daily activities 19 Therefore, a carrier female could lose a sizable component of her muscle fibers before weakness became clinically noticeable. In preliminary studies, we have noted that on exercise testing the female carriers will usually perform below the 30th percentile for their sex and age.21
It seems reasonable to suggest that the carrier state in Duchenne-type muscular dystrophy might be more reliably identified by studies on serum CPK activity and muscle tissue in the young female. The use of muscle testing remains to be more fully evaluated.
Recent genetic evidence may also explain the wide variation found in CPK levels in carrier females, as well as suggesting a reason for the number of clinically affected females reported in the literature. This evidence is based on the studies of Ohno and his associates,22' 23 which revealed that in female somatic cells one X-chromosome becomes hetero-K pyknotic and forms the chromatin or Barr body. Lyon then sugEi gested24 5 that: (a) the heteropyknotic X-chromosome is genetically inactivated; (b) the inactivated X could be either of randomly distributed throughout 4.0, X 390. different cells; and (c) inactivation occurred early in embryonic life, usually by the 12th day in the human embryo.26' 27 In the male, the X-chromosome never becomes heteropyknotic. The female then is composed of a mosaic of somatic cells, some with a maternal X-chromosome that is functional, and others with a functional paternal X. The female who is heterozygous for a sex-linked gene will show considerable variation in gene expression in her somatic cells depending on the proportion of active normal or active mutant-bearing X-chromosomes that exist.
This hypothesis has been supported by studies on coat mottling in the mouse,25 as well as by certain biochemical studies. Beutler and associates28 have demonstrated that the red blood cells of females, heterozygous for glucose-6 phosphate dehydrogenase deficiency, consisted of two populations, one normal and the other devoid of G-6 PD enzyme. Recent studies on X-autosome translocations in mice and investigations of G-6 PD activity in the cell clones derived from single cells strongly support the hypothesis that all females are natural mosaics.29 ' 30 This hypothesis can serve to explain the finding of serum enzyme elevations, especially CPK, and the myopathological changes in female carriers of Duchennetype muscular dystrophy. Hence, a subclinical disorder is present which rarely expresses itself as gross muscular weakness. Two populations of muscle fibers are present, one normal and the other dystrophic. This state is achieved by the operation of X-chromosome mosaicism.
The chance occurrence of lesser degrees of randomization, i.e., a greater number of normal X-chromosomes, could give rise to totally normal, or nearly so, female carriers. 
